젊은 연령에서 발생한 자궁경부암 병기 IB의 수술 및 방사선치료 결과

Therapeutic Results of Surgery and Radiation Therapy in Younger Patients with Stage IB Cervical Cancer

  • 허길자 (인제대학교 부속 서울 백병원 치료방사선과학교실) ;
  • 양광모 (인제대학교 부속 서울 백병원 치료방사선과학교실) ;
  • 서현숙 (인제대학교 부속 서울 백병원 치료방사선과학교실) ;
  • 김용봉 (인제대학교 부속 서울 백병원 산부인과학교실) ;
  • 이응수 (인제대학교 부속 서울 백병원 산부인과학교실) ;
  • 박성관 (인제대학교 부속 서울 백병원 산부인과학교실)
  • Huh Gil Cha (Department of Radiation Oncology, Inje University Paik Hospital, Seoul) ;
  • Yang Kwang Mo (Department of Radiation Oncology, Inje University Paik Hospital, Seoul) ;
  • Suh Hyun Suk (Department of Radiation Oncology, Inje University Paik Hospital, Seoul) ;
  • Kim Yong Bong (Department of Gynecology Oncology, Inje University Paik Hospital, Seoul) ;
  • Lee Eung Soo (Department of Gynecology Oncology, Inje University Paik Hospital, Seoul) ;
  • Park Sung Kwan (Department of Gynecology Oncology, Inje University Paik Hospital, Seoul)
  • 발행 : 1995.03.01

초록

Purpose : To evaluate the prognostic importance of age in patients with Stage IB cervical cancer, we examined the relationship between age and survival in patients. Methods and Materials: Retrospective analysis was performed on 107 patients with Stage IB cervical cancer: 79 patients were treated with surgery followed by postoperative radiotherapy or radiation alone between October 1983 and August 1993 and 28 patients with Stage IB cervical cancer treated with surgery alone between January 1989 and August 1993 at Inje University Seoul Paik Hospital. Patients ranged in age from 26 to 74 (median 48) and were followed for a modian period of 39 months. Patients were divided into two groups; Group A comprising 32 Patients $with{\geq}$age 40 and Group B comprising 75 patients with>age 40. Both Group A and Group B patients were comparable with respect to all covariables studied. Results : The overall 5-year survival and the disease free 5-year survival for the 107 patients studied were $85.2\%$ and $82.1\%$, respectively. The overall survival for Group A and Group B was $92\%$ and $83\%$, respectively(p>0.05). The disease free 5-year survival for Group A and Group B was $82.3\%$ and $82.6\%$, respectively(p>0.05). There was no difference in both local and distant failure in Group A and Group B. Conclusion: On the basis of the this analysis it is concluded that age alone is a poor indicator of prognosis and should not be used as an indication for adjuvant treatment.

키워드